Zusammenfassung
Als an der im Jahre 1905 in Meran stattfindenden Pathologen-Tagung Friedrich von Müller(221) zum ersten Mal den Begriff Nephrose vorschlug, war für ihn die Pathogenese der leitende Gesichtspunkt. Es schien ihm auf Grund morphologischer Kriterien berechtigt zu sein, die degenerativen Nierenerkrankungen von den entzündlichen zu trennen. Der Begriff „Nephritis“sei auf exsudative und proliferative Prozesse der Gefäße zu beschränken. Bei Veränderungen, welche nur degenerativer Art sind oder bei denen die entzündliche Natur nicht über jeden Zweifel erhaben ist, sei die Bezeichnung „Nephrose“angebracht. Schon damals mußte Friedrich von Müller zugeben, daß eine ätiologische Einteilung oft nicht möglich war. Insbesondere seien beim Typus der großen weißen Niere die Fälle kryptogenetischen Ursprungs recht häufig.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Achard, Ch., M. Bariéty, A. Codounis et E. Hadjigeorges: Etude comparative des lipides dans le sang de l’artère et de la veine rénale chez le chien. C. R. Soc. Biol. (Paris) 110, 880 (1932).
Albrink, M. J., P. M. Hald, E. B. Man and J. P. Peters: Displacement of serum water by the lipids. J. clin. Invest. 34, 1483 (1955).
Allen, A. C.: The Kidney, medical and surgical diseases. The Kidney. New York: Grune [and] Stratton 1951.
Armstrong, S. H., B. G. Nelson, L. A. Parness and R. Sight: Molecular weight distributions of the globulins in the nephrotic syndrome. J. clin. Invest. 29, 796 (1950).
Arneil, G. C.: Treatment of nephrosis with Prednisolone. Lancet 19561, 409.
Atlas, D. H., M. M. Cash and M. M. Kirschen: Serum lipids following nephrectomy and in mercuric chloride poisoning. Amer. J. clin. Path. 19, 962 (1949).
Axelrad, B. J., and J. A. Luetscher: Adrenal cortical activity in normal men on diets of low sodium content. J. clin. Invest. 33, 916 (1954).
Baehr, G., P. Klemperer and A. Schifrin: A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Trans. Ass. Amer. Phycns 50, 139 (1935).
In R. L. Cecil and R. F. Loeb: Textbook of Medicine. Philadelphia: Saunders 1952.
Barness, L. A., G. H. Moll and C. A. Janeway: Nephrotic syndrome. J. Pediat. 5, 486 (1950).
Barnett, H., C. Forman and H. McNamara: The effect of adrenocorticotropic hormone on children with the nephrotic syndrome. II. Physiologic observations on discrete kidney functions and plasma volume. J. clin. Invest. 30, 227 (1951).
Barnett, H. L., D. J. Simons and R. E. Wells: Nephrotic syndrome occurring during tridione therapy. Amer. J. Med. 4, 760 (1948).
Bast ai, P., e M. Crepet: La sistemazione fisiopatologica e nosografica della cose della nefrosi lipoidea o genuina. Minerva nefrol. (Torino) 1, 1 (1954).
Baxter, J. H.: In Proc. 1 st Internat. Conf. on Prednisone and Prednisolone. New York 1956.
Bauer, F. C., G. C. Johnson, L. Carbonaro and E. F. Hirsch: Changes in serum lipids of rabbits with acute uranyl nitrate poisoning. Arch. Path. (Chicago) 51, 441 (1951).
Beattie, J. W.: Nephrotic syndrome following sodium bismuth tartrate therapy in rheumatoid arthritis. Ann. rheum. Dis. 12, 144 (1953).
Becker, B., G. D. Maengwyn-Davies, D. Rosen, J. S. Friedenwald and F. C. Winter: The adrenal cortex and B-vit. in diabetic retinopathy. Diabetes 3, 175 (1954).
Bell, E. T.: Renal diseases. Philadelphia: Lea [and] Febiger 1947.
Bell, E. T.: Renal vascular disease in diabetes mellitus. Diabetes 2, 376 (1953).
Bell, E. T.: Diskussion zu: Experimental diabetic glomerulosclerosis. Von J. M. B. Blood- worth jr. and G. J. Hamwi: Diabetes 5, 42 (1956).
Benhamoij, E., A. Albott et P. Grigtjer: Oedèmes irréductibles au cours d’une néphrose lipoidique traités avec succès par la dialyse péritonéale. Bull. Soc. méd. Hôp. Paris 1950, 1293.
Bennhold, H.: Über die Ausscheidung intravenös einverleibten Kongorotes bei den verschiedensten Erkrankungen, insbesondere bei Amyloidosis. Dtsch. Arch. klin. Med. 142, 32 (1923).
Berblinger, W.: Amyloidschrumpfnieren und Hochdruck. Ärztl. Forsch. 6, 449 (1952).
Bergstrand, A., and H. Bucht: The glomerular lesions of diabetes mellitus and their electron microscopic appearance. Lab. Invest. 6, 293 (1957).
Bergstrom, W. H., R. F. Carzoli, C. Lombroso, D. T. Davidson and W. M. Wallace: Observations on the metabolic and clinical effects of carbonic-anhydrase inhibitors in epileptics. Amer. J. Dis. Child. 84, 771 (1952).
Berkman, J., H. Rifkin and G. Ross: Serum Polysaccharids in diabetic patients with degenerative vascular disease. J. clin. Invest. 32, 415 (1953).
Berman, L., A. R. Axelrod, H. L. Goodman and R. I. McClaughry: So-called “lupus erythematosus inclusion phenomenon” of bone marrow and blood; morphologic and serologic studies. Amer. J. elin. Path. 20, 403 (1950).
Berthottd, E., E. Martin et M. Vahdate: Guérison spontanée de la néphrose lipoidique. Rev. méd. Suisse rom. 75, 261 (1955).
Beyer, K. H., J. E. Baer, H. F. Rosso and A. S. Haimbach: Chlorothiazide (6-chloro- 7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide); the enhancement of sodium chloride excretion. Fed. Proc. 16, 282 (1957).
Bickel, G.: Premiers essais cliniques avec la prednisone (métacortandracine ou méti- cortène). Schweiz, med. Wschr. 1955, 859.
Bickel, G. et R. Lasserre: Amyloidose d’évolution rapide chez une tuberculeuse traitée par la cortisone. Bull. Soc. méd. Hôp. Paris 1956, 275.
Bjornboe, M., C. Brun, H. Gormsen, P. Iversen and F. Raaschou: Nephrotic syndrome, histological changes illustrated by means of biopsy of kidney. Acta med. scand. 142, 233 (1952).
Bland, W. H., M. Fields and R. Goldman: Turnover rate of serum albumine in the nephrotic syndrome as determined by I131 labeled albumin. J. Lab. clin. Med. 46, 747 (1955).
Block, W. M., R. L. Jackson, G. Stearns and M. P. Butsch: Lipoid nephrosis. J. Pediat. 1, 733 (1948).
Bogdonoff, M. D., J. Linhart and R. F. Klein: Effect of serum ajbumin infusion upon lipid mobilization in the nephrotic syndrome in man. J. clin. Invest. 40, 1024 (1961).
Bradley, S. E., and C. J. Tyson: Medical progress; “nephrotic syndrome”. New Engl. J. Med. 238, 223, 260 (1948).
Briggs, J. N., and J. L. Emery: Toxic effects of tridione. Lancet 1949 I, 59.
Brumfitt, W., and W. O’Brien: Renal vein thrombosis with nephrotic syndrome and renal failure. Brit. med. J. 1956II, 751.
Burack, R., J. Pryce and J. F. Goodwin: A reversible nephrotic syndrome associated with congestive heart failure. Circulation 18, 562 (1958).
Burnett, C. H., M. A. Greer, B. A. Burrows, J. H. Sisson, A. S. Relman, L. A. Weinstein and C. G. Colburn: The effects of cortisone on the course of acute glomerulonephritis. Report of a case. New Engl. J. Med. 248, 1028 (1950).
Butterworth, C. E.: Production of L. E. cells in normal individuals. J. clin. Invest. 32, 558 (1953).
Calkins, E., and A. S. Cohen: Chemical composition of amyloid. J. clin. Invest. 37, 882 (1958).
Cargill, W. H.: Effect of the intravenous administration of human serum albumin on renal function. Proc. Soc. exp. Biol. (N. Y.) 68, 189 (1948).
Cavelti, R.: Über den Entstehungsmechanismus der Albuminurie bei der Lipoidnephrose. Ultrafiltrationsversuche von Eiweißlipoidlösungen und Nephroseseren. Helv. med. Acta 16, 51 (1949).
Chapman, D. W., F. C. Pannill and R. H. Skaggs: New cation exchange resin in therapy of edematous states. Amer. Practit. 2, 945 (1951).
Chaptal, J., R. Jean, C. Campo et D. Abram: Conceptions actuelles de la néphrose lipoidique et de son traitement. Presse méd. 1955, 264.
Clark, L. D., W. Baver and S. Cobb: Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. New Engl. J. Med. 246, 205 (1952).
Clément, R.: Pyrétothérapie de la néphrose lipoidique pure. Presse méd. 1938, 971.
Cohn, E. J., J. L. Oncley and L. E. Strong: Characterization of protein fraction of human plasma. J. clin. Invest. 23, 417 (1944).
Conte, M., J. J. Welti, J. Ristelhueber, Conte-Marti et C. Julien: Maladie amyloide primitive hépato-cardio-renale. Bull. Soc. méd. Hop. Paris 1958, 275.
Cossel, L., G. Lisewski u. G. Mohnike: Elektronenmikroskopische und klinische Untersuchungen bei diabetischer Glomerulosklerose. Klin. Wschr. 37, 1005 (1959).
Coursaget, J., G. Richet, R. Nordman et J. Hamburger: Elimination urinaire des albumines marquées par l’iode radioactif (I131) chez le sujet atteint de néphrose lipoidique. Bull. Soc. méd. Hôp. Paris 1952, 1178.
Cruchaud, S., C. Mahaim, B. Scazziga et A. Vannotti: Fonction thyroidienne et néphrose lipoidique. Schweiz, med. Wschr. 1954, 478.
Cruchaud, S., C. Mahaim, Syndrome néphrotique dans un cas de thrombose bilatérale des veines rénales. Helv. med. Acta 23, 495 (1956).
Davis, J. O., C. R. Ayer and C. J. Carpenter: Renal origin of an aldosterone-stimulating hormone in dogs. J. clin. Invest. 40, 1466 (1961).
Daysog, A., H. L. Dobson and J. C. Brennan: Renal glomerular and vascular lesions in diabetes mellitus. Ann. intern. Med. 54, 672 (1961).
Debré,R., P.Royer, B.Lévêque et Z. Minor: Le traitement discontinu prolongé du syndrome néphrotique de l’enfant par l’ACTH et la cortisone. Sem. Hôp. Paris 32, 263 (1956).
J. Marie, P. Royer, B. Lévêque et L. Kaplan: Pronostic éloigné du syndrome néphrotique de l’enfant (193 observations). Sem. Hôp. Paris (Ann. Péd.) 36, 531 (1960).
Deparis, M., L. Auquier, J. Canivet, R. Levillain et J. Limac: Thrombose des veines rénales et néphrose lipoidique. Presse méd. 62, 1363 (1954).
Dévot, M., et J. J. Bernier: La cholestérolémie au cours des néphrites. Rapport aux Journées du Cholestérol. Vittel (1952).
Derow, H. A., M. J. Schlesinger and H. A. Savitz: Chronic progressive occlusion of inferior vena cava and renal and portal veins, with clinical picture of nephrotic syndrome: report of 1 case, with review of the literature. Arch, intern. Med. 63, 626 (1939).
Dillon, J. A., and L. R. Evans: Primary amyloidosis, report of 3 cases. Ann. intern. Med. 17, 722 (1942).
Dock, W.: Sodium depletion as therapeutic procedure; value of ion-exchange resins in withdrawing sodium from body. Trans. Ass. Amer. Phycns 59, 282 (1946).
Drabkin, D. L., and J. B. Marsch: Metabolic chanelling in experimental nephrosis. J. biol. chem. 212, 623 (1955).
Dubach, U. C., u. L. Recant: Aminonucleosid-Nephrose. Klin. Wschr. 38, 1177 (1960).
Dubois, E. L.: Acquired hemolytic anemia in lupus erythematodes disseminatus. Amer. J. Med. 12, 197 (1952).
Dubois, E. L.: Current therapy of systemic lupus erythematosus. J. Amer. med. Ass. 173, 1633 (1960).
Earle, D. P., J. D. Alexander, S. J. Färber and E. D. Pellegrino: Observation on the relation of renal function changes to the electrolyte and glycosurie effects of ACTH. In Proc. 2nd clin. ACTH conf. Blakiston Philadelphia: 1951.
Eberlein, W. R., and A. M. Bongiovanni: Steroid metabolism in the salt-losing form of congenital adrenal hyperplasia. J. clin. Invest. 37, 889 (1958).
Eder, H. A., F. P. Chinard, P. A. Greif, G. C. Cotzias, A. Hiller, D. D. van Slyke and H. D. Lauson: A study of the changes in plasma volume, renal function induced by repeated administration of albumin. J. clin. Invest. 27, 532 (1948).
H. D. Lauson, F. P. Chinard, R. L. Greif, G. C. Cotzias and D. D. van Slake: A study of the mechanisms of edema formation in patients with the nephrotic syndrome. J. clin. Invest. 33, 636 (1954).
Edmonds, C. J.: An aldosterone antagonist and diuretics in the treatment of chronic edema. Lancet 1960 I, 509.
Emerson, K. jr., and W.W. Beckman: Calcium metabolism in nephrosis. J. clin. Invest. 24, 564 (1945).
Enderlin, M., H. U. Zollinger, 0. Spühler and H. Wipf: Die Masugi-Nephritis unter Cortison. H.lv. med. Acta 18, 525 (1951).
Engelberg, H., J. Gofman and H. Jones: Serumlipids and lipoproteins in diabetic glomerulosclerosis. Diabetes 1, 425 (1952).
Epstein, A.: Über Diabetes albuminuricus, die sog. chronische Nephrose. Arch. Verdau.- Kr. 44, 31 (1928).
Escher, F., u. P. Ludi: Hypophysektomie bei metastasierendem Mammacarcinom. Schweiz, med. Wschr. 91, 709 (1961).
Fabre, J.: Le traitement des oedèmes. Helv. med. Acta 23, 381 (1956).
Fahr, T.: Über Glomerulosklerose. Virchows Arch. path. Anat. 309, 16 (1942).
Fanconi, G., C. Kotjsmine u. W. Frischknecht: Die konstitutionelle Bereitschaft zum Nephrosesyndrom. Helv. paediat. Acta 6, 199 (1951).
Einleitung zur Panel Discussion über: Nephrose. In Pathogenese u. Therapie der Oedeme. Basel: Benno Schwabe 1961.
Farqtjhar, M. G., R. L. Vernier and R. A. Good: Application of electron microscopy in pathology: study of renal biopsy tissues. Schweiz, med. Wschr. 1957, 501.
Farqtjhar, M. G., Review of electron microscopic glomerular pathology. In Proc. of the 10 th annual Conf. on the nephrotic syndrome New York 1958.
Farr, L. E., J. E. Smadel and R. F. Holden: Observations on occurrence of lipemia in rats with nephrotoxic nephritis. Proc. Soc. exp. Biol. (N. Y.) 51, 178 (1942).
Feinberg, S. M. and A. R., and E. W. Fisherman: Triamcinolone (Aristocort), new corticosteroid hormone. J. Amer. med. Ass. 167, 58 (1958).
Ferris, T. F., W. S. Morgan and H. Levitios: Nephrotic syndrome caused by Probenecid. New Engl. J. Med. 265, 381 (1961).
Fiessinger, N., J. Fauvet et C. Albahary: Un cas d’amylose hépatique et cutanée. Bull. Soc. méd. Hôp. Paris 58, 274 (1942).
Fishberg, E.H.: The relations of the serum proteins and lipids to the osmotic pressure. J. biol. chem. 81, 205 (1929).
Fishberg, A. M.: Hypertension and nephritis. Philadelphia: Lea [and] Febiger 1954.
Folli, G., Y. E. Pollar, R. T. W. Reid, C. L. Pirani and R. M. Kark: Electron- microscopic studies of reversible glomerular lesions in the adult nephrotic syndrome. Ann. intern. Med. 49, 775 (1958).
Ford, R. V., J. H. Moyer and C. L. Sptjrr: Clinical and laboratory observations on Chlorothiazide (Diuril). Arch, intern. Med. 100, 582 (1957).
Franke, H., u. H. Wördehoff: Zur Diagnose und Therapie der sog. Libman-Sacksschen Erkrankung. Z. klin. Med. 148, 396 (1951).
Frenk, S., I. Antonowicz, J. M. Craig and J. Metcoff: Experimental nephrotic syndrome induced in rats by aminonucleoside. Renal lesions and body electrolyte composition. Proc. Soc. exp. Biol. (N. Y.) 89, 424 (1955).
Frenkel, M., u. J. Groen: Amyloidosis na Behandeling met ACTH. Ned. T. Geneesk. 98, 2352 (1954).
Frey, W.: Die hämatogenen Nierenerkrankungen. Hdb. inn. Med. 4. Aufl. Bd. 8. Berlin-Göttingen-Heidelberg: Springer 1951.
Friedrich, J., A. Prader u. G. Fanconi: Häufigkeit, Prognose und Behandlung des Nephrosesyndroms. Helv. paediat. Acta 9, 109 (1954).
Friedberg, C. K., M. Halpern and R. Taymor: The effect of intravenously administered 6063, the carbonic anhydrase inhibitor, 2-acetylamino-l,3,4-thiadiazole-5-sulfonamide, on fluid and electrolytes in normal subjects and patients with congestive heart failure. J. clin. Invest. 31, 1074 (1952).
Friederiszick, F. K., u. E. Hoffecker: Die Prednison-Therapie der Nephrose im Kindesalter. Med. Klin. 51, 1260 (1956).
Galeone, A., e A. M. Pelocchino: Sull’attività lipasica del rene in varie nefropatie, sperimentali e dell’uomo. Minerva nefrol. (Torino) 1, 106 (1954). Ergebnisse d. inn. Medizin, N. F., Bd. 18 24
Gautier, E., W. Hitzig, E. Gugler u. M. Bertschmann: Humorale Abwehr beim nephrotischen Syndrom. Helv. paediat. Acta 16, 277 (1961).
Gellmann, D.., C. L. Pirani and J. F. Soothill: Diabetic nephropathy. A clinical and pathologic study based on renal biopsies. Medicine 38, 321 (1959).
Genest, J., W. Nowaczynski, E. Koiw, T. Sandor u. P. Biron: Nebennierenrinden- funktion bei essentieller Hypertonie. In Reubi, F., K. D. Bock u. P. Cottier: Essentielle Hypertonie. Berlin-Göttingen-Heidelberg: Springer 1960.
DeGennes, L., H. Bricaire, J. Courjaret et H. Deschamps: Le traitement des rétentions hydrosodiques par les résines échangeuses d’ions (Etude de 15 obsérvations). Bull. Soc. méd. Hôp. Paris 1952, 724.
Gérard, P., et R. Cordier: Comment interpréter les formations granulaires rencontrées dans le tube contourné du rein, chez les vertébrés ? Bull. Acad. roy. Méd. Belg. 1934, 160.
Gerber, I. E.: Amyloidosis of the bone marrow. Arch. Path. (Chicago) 17, 620 (1934).
Gibson, S. T.: Medical progress; blood and its derivatives. New Engl. J. Med. 239, 544, 579 (1948).
Giles, R. B. jr., and E. Calkins: Studies of the composition of secondary amyloid. J. clin. Invest. 34, 1476 (1955).
Gitlin, D., and C. A. Janeway: Immunochemical study of the albumin of serum and urine in the nephrotic syndrome. J. clin. Invest. 31, 222 (1952).
and L. E. Farr: Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Albumin, y-globulin and iron binding globulin. J. clin. Invest. 35, 44 (1956).
Gobbato, F., P. Chiesura e G. Monarca: Compostamento della funzione renale nell’in- tossicazione professionale da mercurio. Minerva nefrol. (Torino) 1, 125 (1954).
Goetz, F. C., J. F. Hartmann and A. Lazarow: Electron microscopy of the human glomerulus in early diabetes. J. clin. Invest. 39, 991 (1960).
Goldmann, H.: Persönliche Mitteilung.
Goodman, H. C., and J. H. Baxter: The nephrotic syndrome — clinical observation on therapy with Prednisone and other steroids. Amer. med. Ass. 165, 1798 (1957).
Govaerts, P., et R. Cordier: Contribution à l’étude clinique et anatomique de la néphrose lipoidique. Bull. Acad. roy. Méd. Belg. 1928, 510.
Govaerts, P., Le fonctionnement du rein malade. Paris: Masson 1936.
Govaerts, P., et P. P. Lambert: Physiopathologie de la protéinurie. J. Urol. méd. chir. 59, 693 (1953).
Grégoire, F., C. Malmendier et P. P. Lambert: Syndrome néphrotique après traitement aux sels d’or. J. Urol. méd. chir. 62, 140 (1956).
Gribetz, D.: In Proc. of the 10th annual Conf. on the nephrotic syndrome. New York (1958).
Gross, F.: Nebennierenrindenfunktion und renale Pressormechanismen bei exp. Hypertension. In Reubi, F., K. D. Bock u. P. Cottier: Essentielle Hypertonie. Berlin- Göttingen- Heidelberg: Springer 1960.
Haemmerli, A.: Klinische Aspekte der primären Amyloidose. Schweiz, med. Wschr. 1954, 1262.
Hamburger, J.: Reflexions sur la néphrose lipoidique. Rev. franç. Et. clin. biol. 1, 143 (1956).
Hargraves, M. M., H. Richmond and R. Morton: Presentation of two bone marrow elements: the “tart” cell and the “L. E.” cell. Proc. Mayo Clin. 23, 25 (1948).
Hargraves, M. M., Some supravital observations on the “L. E.” phenomenon. Amer. J. Med. 12, 422 (1952).
Harrison, C. V., M. D. Milne and R. E. Steiner: Clinical aspects of renal thrombosis. Quart. J. Med. 25, 285 (1956).
Harvey, A. M., L. E. Shulman, P. A. Tumulty, C. L. Conley and E. H. Schoenrich: Systemic lupus erythematodes: review of the literature and clinical analysis of 138 cases. Medicine 33, 291 (1954).
Hartroft, W. S.: Fat emboli in glomerular capillaries of choline-deficient rats and of patients with diabetic glomerulosclerosis. Amer. J. Path. 31, 381 (1955).
Hasson, J., J. T. Berkman, J. G. Parker and H. Rifkin: Clinicopathologic study of chronic renal vein thrombosis in adults. Ann. intern. Med. 47, 493 (1957).
Haugen, H. N.: Tridione nephropathy. Acta med. scand. 159, 375 (1957).
Heidorn, G. H., and F. R. Schemm: The clinical use of corticotropin (ACTH) and adrenal corticosteroids in the therapy of intractable edema. Amer. J. med. Sei. 229, 621 (1955).
Heilmeyer, L., u. O. Lippross: Über doppelseitige Nierenthrombose bei Erwachsenen. Dtsch. Arch. klin. Med. 179, 80 (1937).
Hollman, L., B. Zumoff, N. Kretchmer and Mitarb.: Amer. J. Dis. Child. 94, 437 (1957).
Herken, H.: Die Therapie von Oedemen mit Kationenaustauschern. Dtsch. med. Wschr. 1953, 8.
Herken, H.: Die Regulation der gestörten Diurese durch Pharmaka. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 238, 158 (1960).
Hernberg, C. A., G. Björkesten and S. V annas: Hypophysectomy in the treatement of retinopathy and nephropathy in severe juvenile diabetes. Acta endocr. (Kbh.) 31, 241 (1959).
Hestetun, S.: Congenital lipoid nephrosis. Nord. Med. 49, 215 (1953).
Heymann, W.: Renal hyperlipemia in dogs. Science 96, 163 (1942).
Heymann, W. and H. Z. Lund: Nephrotic syndrome in rats. Pediatrics 7, 691 (1951).
Heymann, W., H. Z. Lund and D. B. Hackel: Nephrotic syndrome in rats; with special reference to progression of glomerular lesions and to use of nephrotoxic sera obtained from duck. J. Lab. clin. Med. 39, 218 (1952).
Heymann, W., and E. C. Clark: Nephrotic hyperlipemia. Amer. J. Dis. Child. 70, 74 (1954).
Heymann, W., G. Nash, C. Gilkey and M. Lewis: Studies on the causal role of hypoalbuminemia in exp. nephrotic hyperlipemia. J. clin. Invest. 37, 808 (1958).
D. B. Hackel and J. L. P. Hunter: Trimethadione nephrosis in rats. Pediatrics 25, 112 (I960).
D. B. Hackel and J. L. P. Hunter: Experimental nephrosis. In Pathogenese und Therapie der Oedeme. 150. Basel: Benno Schwabe 1961.
Hogeman, O.: Clearance tests in renal disordre and hypertension. Renal function in diabetic nephropathy. Acta med. scand. Suppl. 216B (1949).
Holmes, C. B., G. C. Walsh and M. M. Baird: Effect of cortisone on nephrotic syndrome occurring in diabetics. Canad. med. Ass. J. 65, 26 (1951).
Howe, J. S.: Renal biopsy in renal disease. In Proc. 7 th Conf. on nephrotic syndrome. New York 1955.
Hunter, J. L. P., D. B. Hackel and W. Heymann: Nephrotic syndrome in rats produced by sensitization to rat kidney proteins. J. Immunol. 85, 319 (1960).
Jacobson, W. E., B. I. Heller and J. F. Hammersten: Effect of cortisone in glomerulonephritis and nephropathy of disseminated lupus erythematosus. Minn. Med. 34, 541 (1951).
Jaffe, R. H.: Amyloidosis produced by injections of proteins. Arch. Path. (Chicago) 1, 25 (1926).
Imhof, P., H. M. Keller, B. Notter, P. Spirig, J. Paris u. F. Reubi: Wirkung eines unspezifischen Reizstoffes (Sä 1083/IV) auf Blutdruck, Herzminutenvolumen und Nierenfunktion beim Hypertoniker. Helv. med. Acta 23, 515 (1956).
Ingbar, S. H., E. H. Kass, C. H. Burnett, A. S. Belman, B. A. Burrows and J. H. Sisson: Effects of ACTH and cortisone on the renal tubular transport of uric acid, P, and electrolytes in patients with normal renal and adrenal function. J. Lab. clin. Med. 38, 533 (1951).
James, J., G. Gordillo and J. Metcoff: Effects of infusion of hyperoncotic dextran in children with the nephrotic syndrome. J. clin. Invest. 33, 1346 (1954).
Janeway, C. A., S. T. Gibson and L. M. Woodruff: Concentrated human serum albumin: albumin in treatment of shock; safety of alubmin; albumin in treatment of hypoproteinemia. J. clin. Invest. 23, 465 (1944).
Jimenez-Diaz, C.: Nature et signification de la dite nephrose chronique ou lipoidique. Schweiz, med. Wschr. 1950, 965.
Johnson, G. C., F. C. Bauer, E. F. Hirsch and L. Carbonaro: Lipemia of rabbits following unilateral occlusion of renal vessels. Arch. Path. (Chicago) 52, 115 (1951).
Kagawa, C. M., J. A. Cella and C. G. van Arman: Action of new steroids in blocking effects of aldosterone on salt. Science 120, 1015 (1957).
Kaitz, A. L.: Albumin metabolism in nephrotic adults. J. Lab. clin. Med. 53, 186 (1959).
Keiding, N. R., G. V. Mann, H. F. Root, E. Y. Lawry and A. Marble: Serum lipoproteins and cholesterol levels in normal subjects and in young patients with diabetes in relation to vascular complications. Diabetes 1, 434 (1952).
H. F. Root and A. Marble: Importance of control of diabetes in prevention of vascular complications. J. Amer. med. Ass. 150, 964 (1952).
Keitel, H. G., H. C. Goodman, R. J. Havel, R. S. Gordon and J. H. Baxter: Nephrotic syndrome in congenital quartan malaria. J. Amer. med. Ass. 161, 520 (1956).
Keith, H. M.: Types and treatment of nephritis in children. Med. Clin. N. Amer. 1951, 1069.
Keith, N. M., M. H. Power and G. W. Daugherty: Action of cortisone in nephritis with edema. Proc. Mayo Clin. 25, 491 (1951).
Keller, H.: Blutcholesterin, Albuminurie und histologische Veränderungen bei einer chronischen Vergiftung mit Urannitrat am Kaninchen. Ein Beitrag zur Frage der experimentellen Nierenerkrankungen. Helv. med. Acta 20, 157 (1953).
Keller, H. M.: Ergebnisse der Knochenmarksfunktionsprüfung bei apyrogenen Dosen eines unspezifischen Reizstoffes (Sä 1083 II/IV) bei Splenomegalien. Helv. med. Acta 23, 656 (1956).
Keller, U. C., M. R. Ziegler, D. Doeden and I. McQijarrie: Labeled Methionine as an indicator of protein formation in children with lipoid nephrosis. Proc. Soc. exp. Biol. (N. Y.) 75, 153 (1950).
Kimmelstiel, P., and C. Wilson: Intercapillary lesion in the glomeruli of the kidney. Amer. J. Path. 12, 83 (1936).
Klemperer, P., A. D. Pollak and G. Baehr: Diffuse collagen disease. Acute disseminate lupus erythematosus and diffuse scleroderma. J. Amer. med. Ass. 119, 331 (1942).
Klemperer, P., A. D. Pollak and G. Baehr: Role of connective tissue in diseases of cardiovascular system. Bull. N. Y. Acad. Med. 28, 204 (1952).
Knowlton, A. I.: Diskussion zu: Hypoadrenal function and adrenalectomy in human diabetes. By Graef, I.: Diabetes, 5, 243 (1956).
Kratjpp, 0., W. Rupp, W. Swoboda u. E. Zweymüller: Veränderungen des Elektrolythaushaltes beim Nephrose-Syndrom durch Kationenaustauscher- und ACTH-Verabrei- chung. Schweiz, med. Wschr. 1954, 666.
Krawkow, N. P.: Amyloidose expérimentale. Arch. Méd. exp. 8, 106 (1896).
Kurnick, N. B.: Zit. durch Lee, S. L., S. R. Michael and I. L. Voral: The L. E. (Lupus Erythematosus) Cell. Amer. J. Med. 10, 446 (1951).
Kuczyorski, M. H.: Neue Beiträge zur Lehre vom Amyloid. Klin. Wschr. 1923, 727.
Lagrue, G., P. Milliez, B. N. Halpern et A. Brannelec: Les thromboses des veines rénales. III. Etude expérimentale. J. Urol. méd. chir. 63, 588 (1957).
Lambert, P. P.: Sur les potentialités de résorption du tube contourné chez les urodèles. C. R. Soc. Biol. (Paris) 110,114 (1932); Sur l’existence d’un gradient de perméabilité dans les néphrons ouverts des urodèles. C. R. Soc. Biol. (Paris) 114, 1370 (1933).
Lambert, P. P.: Polycystic disease of kidney. Arch. Path. (Chicago) 44, 34 (1947).
Lange, K., L. B. Slobody and R. H. Strang: Prolonged intermittent corticotropin (ACTH) and Cortisone therapy in the nephrotic syndrome. Amer. J. Dis. Child. 86, 478 (1953).
Laroche, C., J. Crfveiller, J. Hazard et J. Trtjffert: Emploi des résines échangeuses de cations dans la thérapeutique des oedèmes (Etude de 17 cas). Bull. Soc. méd. Hôp. Paris 1952, 759.
Lee, R. E., R. L. Vernier and R. A. Ulstrom: Nephrotic syndrome as a complication of Perchlorate treatment of thyreotoxicosis. New Engl. J. Med. 264, 1221 (1961).
Léger, L., et L. A. George: Thrombose de la veine rénale. Presse méd. 62, 721 (1954).
Letterer, E.: Neue Untersuchungen über die Entstehung des Amyloids. Virchows Arch. path. Anat. 293, 34 (1934).
Liddle, G. W.: Sodium diuresis induced by steroidal antagonists of aldosterone. Science 126, 1016 (1957).
Lindsay, S.: Primary systemic amyloidosis with nephrosis. Amer. J. Med. 4, 765 (1948).
Lippman, R. W.: Sodium absorbent cation exchange resin in the treatment of nephrotic edema. Amer. J. Med. 10, 776 (1951).
London, I. M., G. F. Sabella and M. M. Yamasaki: Studies on the metabolism of cholesterol in normal man and in the nephrotic syndrome. J. clin. Invest. 30, 657 (1951).
Longsworth, L. G., and D. A. McInnes: An electrophoretic study of nephrotic sera and urine. J. exp. Med. 71, 77 (1940).
Ltjbarsch, O.: Zur Kenntnis ungewöhnlicher Amyloidablagerungen. Virchows Arch, path. Anat. 271, 867 (1929).
Luetscher, J. A.: Serum albumin. II. Identification of more than one albumin in horse and human serum by electrophoretic mobility in acid solution. J. Amer. ehem. Soc. 61, 2888 (1939). Electrophoretic analysis of plasma and urinary proteins. J. clin. Invést. 19, 313 (1940); Electrophoretic analysis of proteins of plasma and serous effusions. J. clin. Invest. 20, 99 (1941).
A. D. Hall and V. L. Kremer: Treatment of nephrosis with concentrated human serum albumin. I. effects on the proteins of body fluids. J. clin. Invest. 28, 700 (1949); II. effects on renal functions. J. clin. Invest. 29, 896 (1950).
Q. B. Deming: Bioassay of sodium-retaining corticoids and some changes in excretion of these substances in disease. In renal function Tr. 2nd Conf. J. New York: Macy Foundation 1950.
Q. B. Deming: Treatment of nephrosis with cortisone. J. clin. Invest. 29, 1576 (1950).
Q. B. Deming: and B. B. Johnson: Treatment of nephrosis with ACTH. J. clin. Invest. 30, 1530 (1951).
Q. B. Deming: Problems of electrolyte and water balance in nephrotic syndrome. Arch, intern. Med. 95, 380 (1955).
Q. B. Deming, and R. H. Curtis: Relationship of aldosterone in urine to sodium balance and to some other endocrine functions. J. clin. Invest. 34, 951 (1955).
Luft, R., H. Olivecrona, D. Ikkos, T. Kornerup and H. Ljunggren: Hypophysecto- my in man. Further experience in severe diabetes mellitus. Brit. med. J. 1955 II, 752.
Lund, R. P., and C. Tillgren: Nephrosis in chronic mercurial poisoning. Nord. Med. 50, 1018 (1953).
Lynch, M. J., and S. S. Raphael: The nature of diabetic glomerulosclerosis. Diabetes 6, 488 (1957).
Mach, R. S., et J. Barrelet: Psychose après cortisone. Praxis 39, 875 (1950).
Macheboeuf, M.: Les cénapses lipido-protéidiques. In Polonowski, M.: Exp. annuels de biochimie 5e série. Paris: Masson 1945.
Malmendier, C., et P. P. Lambert: Etude sur la concentration en sérumalbumine du filtrat glomérulaire chez le chien. J. Urol. méd. chir. 61, 327 (1955).
McManus, J. F. A.: Development of intercapillary glomerulosclerosis. Proc. Amer. Diab. Ass. 9, 303 (1950).
Marie, J., P. Seringe et C. Polonovski: Sur 37 néphroses lipoidiques de l’enfant suivies de 2–16 années. Ann. Méd. 55, 252 (1954).
Marko Witz, H., C. G. Gubler and D. P. Mahoney: Copper métabolism (in patients with nephrotic syndrome). J. clin. Invest. 34, 1498 (1955).
Martin, E., et P. Alphonse: La glomérulosclerose diabétique de Kimmelstiel et Wilson. Paris méd. 1946, 364.
Martin, H. E., and M. L. Wilson: Adrenalectomy in human diabetes. 1 case of glomerulosclerosis. Diabetes 3, 375 (1954).
Martini, G. A.: Beitrag zum Heilverlauf der Amyloidnephrose. Klin. Wschr. 1952. 934.
Mateer, F. M., L. H. Erhard, M. Price, F. A. Weigand, J. H. Peters, T. S. Danowski, R. Tarail and L. Greenman: Sodium restriction and cation exchange resin therapy in nephrotic children. J. clin. Invest. 30, 1018 (1951).
Mériel, P., F. Galinier, G. Moreau, G. Bastide, J.-M. Suc et J. P. Bounhoure: Deux nouveaux cas de thrombose veineuse rénale avec syndrome néphrotique: intérêt diagnostique de l’association de la cavographie à la ponctionbiopsie rénale. Bull. Soc. méd. Hôp. Paris 75, 109 (1959).
Metcoff, J., W. Kelsey, C. P. Rance and C. A. Janeway: Effects of ACTH on the pathologie physiology and clinical course of the nephrotic syndrome in children. In Proc. 2nd clin. ACTH Conf. Philadelphia: Blakiston 1951.
Michie, A. J., N. S. Gimbel and C. Riegel: Renal hemodynamics during short and long periods of salt poor albumin administration. Fed. Proc. 8, 110 (1949).
Michielsen, P.: Apport de la microscopie électronique à la connaissance du syndrome néphrotique. Actualités néphrologiques de l’Hôpital Necker. Paris: Flammarion 1960.
Miller, F., u. A. Bohle: Vergleichende Licht- und Elektronenmikroskopische Untersuchungen an der Basalmembran des Glomerulum-Kapillaren der Maus bei experimentellem Nierenamyloid. Klin. Wschr. 1950, 1204.
Miller, G., J. C. Hoyt and B. E. Pollock: Bilateral renal vein thrombosis and the nephrotic syndrome. Amer. J. Med. 17, 856 (1954).
Milliez, P., G. Lagrue, Y. de Barochez et P. Samarcq: Les thromboses des veines rénales. J. Urol. méd. chir. 63, 569 (1957).
C. Laroche, R. Wolfromm, P. Samarcq et G. Lagrue: Etude clinique, biologique et anatomique de 31 cas d’amylose rénale. J. Urol. méd. chir. 64, 544 (1958).
G. Lagrue: Traitement et pronostic du syndrome néphrotique. In Actualités néphrologiques de l’Hôpital Necker. Paris: Flammarion 1960.
Moench, A., u. H. Sartorius: Klinische Untersuchungen über Testosteronbehandlung beim nephrotischen Syndrom. Klin. Wschr. 1954, 329.
Mohnicke, G., u. H. Richter: Über den Eiweißzucker bei Diabetikern. Z. klin. Med. 153, 236 (1955).
Moser, H. W., and K. Emerson: Phospholipid turnover time in nephrotic syndrome. J. clin. Invest. 34, 1286 (1955).
Muehrcke, R. C., R. M. Kark, C. L. Pirani and C. E. Pollak: Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine 36, 1 (1957).
Müller, A. F.: Persönliche Mitteilung.
Müller, F.: Morbus Brighti. Verh. dtsch. Ges. Path. 1905, 64.
Munck, 0., and N. I. Nissen: Development of nephrotic syndrome during treatment with mercurial diuretics. Acta med. scand. 153, 307 (1956).
Naffah, J.: Néphrose lipoidique. Dissertation, Paris (1953).
Nabarro, J. D. N., and M. L. Rosenheim: Nephrotic syndrome complicating tridione (Troxidone) therapy. Lancet 1952 I, 1091.
Nekludow, W. N.: Über die gegenwärtigen Bereicherungen zwischen Cholesterin und einigen Eiweißfraktionen. Z. exp. Med. 47, 70 (1925).
Nonnenbuch, W.: Das nephrotische Syndrom. Klin. Wschr. 1942, 805.
Oliver, J.: Renal morphology. Harvey Lect. 40, 124 (1944–45).
M. MacDowell and Y. C. Lee: Cellular mechanisms of protein metabolism in the nephron. I. The structural aspects of proteinuria; tubular absorption, droplet formation and the disposal of proteins. J. exp. Med. 99, 589 (1954).
Orloff, J., L. G. Welt and L. Stowe: The effects of concentrated salt-poor albumin on the metabolism and excretion of water and electrolytes in nephrosis and toxemia of pregnancy. J. clin. Invest. 29, 770 (1950).
Payne, W. W., and R. H. Wilkinson: Nephrotic oedema treated with an ion-exchange resin. Lancet 1951II, 101.
Peters, J. P., H. A. Btjlger, C. Lee and C. F. Murphy: The relation of albuminuria to protein requirement in nephritis. Arch, intern. Med. 37, 153 (1926).
E. B. Man: Interrelation of serum lipids in patients with diseases of the kidney. J. clin. Invest. 22, 721 (1943).
D. D. van Slyke: Quantitative clin, chemistry. Interpretations. 2. Aufl. Baltimore: Williams [and] Wilkins 1946.
Pollak, V. E., R. M. Kark, C. L. Pirani, H. A. Shafter and R. C. Muehrcke: Renal vein thrombosis and the nephrotic syndrome. Amer. J. Med. 21, 496 (1956).
J. F. Soothill and R. C. Muehrcke: The significance and potential value of renal biopsy in Bright’s disease. J. chron. Dis. 5, 67 (1957).
G. Folli and C. L. Pirani: On the electron microscopic recognition and clinical cure of lipoid nephrosis in adults. J. clin. Invest. 37, 922 (1958).
Pop Jak, G., and E. F. McCarthy: Osmotic pressures of exp. and human lipaemic sera. Biochem. J. 37, 702 (1943); 40, 789 (1946).
Potvliège, P., F. Grégoire, C. Malmendier, L. Desclin et P. P. Lambert: Un cas d’amyloidose rénale d’étiologie inconnue. J. Urol. méd. chir. 64, 149 (1958).
Poulsen, J. E.: Recovery from retinopathy in a case of diabetes with dimmonds disease. Diabetes 2, 7 (1953).
Quarton, G. C., L. D. Clark, S. Cobb and W. Bauer: Mental disturbances associated with ACTH and cortisone. Medicine 34, 13 (1955).
Randerath, E.: Nephrose-Nephritis. In Becher, E.: Nierenkrankheiten. Jena: Fischer 1947.
Rayer, P.: Traité des maladies des reins. Paris: Baillière 1847.
Recant, L., and D. S. Riggs: Thyroid function in nephrosis. J. clin. Invest. 31, 789 (1952).
Reece, J. M., and T. B. Reynolds: Amyloidosis complicating rheumatoid arthritis. Amer. J. med. Sei. 228, 554 (1954).
Reese, H.: Zur Symptomatologie der Nierenvenenthrombose. Dtsch. Arch. klin. Med. 78, 588 (1903).
Reinen, M.: Effect of cortisone and ACTH on serum proteins in disseminated lupus erythematosus. Proc. Soc. exp. Biol. (N. Y.) 74, 529 (1950).
Reinmann, H. A.: Recovery from amyloidosis. J. Amer. med. Ass. 104, 1070 (1935).
Report of the council on pharm, and chem. Human serum albumin in nephrosis. J. Amer, med. Ass. 136, 251 (1948).
Reubi, F.: L’influence du foie sur la constitution des lipoprotéines sériques. Helv. med. Acta 15, 262 (1948). Contrôle clinique du test de l’extractibilité du cholesterol serique par l’éther. Schweiz, med. Wschr. 1951, 330.
Reubi, F., F. Wüthrich, R. Witmer et P. Cottier: Modalités de la rémission dans le syndrome néphrotique traité par l’ACTH. J. Urol. méd. chir. 58, 740 (1952).
Reubi, F.: The nephrotic syndrome. Letter to the Editor. Brit. med. J. 1954 I, 705.
Reubi, F.: et A. Schmid: L’hyperlipidémie du syndrome néphrotique est-elle d’origine renale ? J. Urol. méd. chir. 61, 304 (1955).
Reubi, F.: A propos de la pathogénie du syndrome néphrotique. Helv. med. Acta 22, 514 (1955).
Reubi, F.: Physiopathologie et clinique des néphrites glomérulaires. J. Urol. méd. chir. 61, 625 (1955).
Reubi, F.: L’hyperchlorémie du syndrome néphrotique. Schweiz, med. Wschr. 1957, 393.
Reubi, F.: Effects de la d,l-aldostérone synthétique chez des sujets oedématiés. Rev. franç. Et. clin. biol. 3, 693 (1958); Schweiz, med. Wschr. 1959, 373.
Reubi, F.: Note sur la pyrétothérapie du syndrome néphrotique. Ther. Umsch. 1958, 320.
Reubi, F.: Die Anwendung von Diuretica bei Nierenkrankheiten. Diurese und Diuretica. Berlin-Göttingen-Heidelberg: Springer 1959.
Reubi, F.: Unveröffentlichte Resultate.
Reubi, F.: Nierenkrankheiten. Bern: Hans Huber 1960.
Reubi, F. and P. Cottier: Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation 23, 200 (1961).
Rifkin, H., L. Leiter and J. Berkman: Diabetic glomerulosclerosis. Springfield, 111.: Thomas 1952.
Rifkin, H., L. and M. L. Peterman: Serum and urinary proteins in diabetic glomerulosclerosis. Diabetes 1, 28 (1952).
S. Solomon and S. Lieberman: Role of adrenalcortex in diabetic retinpathy and nephropathy. Diabetes 7, 9 (1958).
Riva, G.: Zur Frage der chronischen Quecksilbernephrose. Helv. med. Acta 12, 539 (1945).
Robbins, S. L., J. Rogers and 0. J. Wollenman: Intercapillary glomerulosclerosis. III. Pathological study. Amer. J. Med. 12, 700 (1952).
Robbins, J., J. E. Rall and M. L. Peterman: Protein-binding of thyroxine in normal and nephrotic serum. J. clin. Invest. 33, 959 (1954).
Rogers, J., and S. L. Robbins: Intercapillary glomerulosclerosis. I. Specificity of the clinical syndrome. Amer. J. Med. 12, 688 (1952).
Röhn, R. J., and W. H. Bond: Some supravital observations on the LE phenomenon. Amer. J. Med. 12, 422 (1952).
Rosen, D. A., B. Becker, G. D. Maengwyn-Davies and J. S. Friedenwald: Influence of heparin on the cortisone nephropathy of rabbits. Bull. Johns Hopk. Hosp. 95, 144 (1954).
Rosenman, R. H., M. Friedman and S. O. Byers: The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia. J. clin. Invest. 35, 522 (1956).
Ross, J. H., and I. P. Ross: The value of renal biopsy. Lancet 1957 II, 559.
Rottssy, G., R. Leroux et C. Oberling: Précis d’anat. pathol. Paris: Masson 1933.
Sarre, H.: Nierenkrankheiten. Stuttgart: Thieme 1958.
Seegal, D., and A. R. Wertheim: Recent advances in our knowledge concerning the nephrotic syndrome. Bull. N. Y. Acad. Med. 25, 605 (1949).
Sézary, A.: Dermatologie. Paris: Masson 1937.
Shearn, M. A., and B. Pirofsky: Disseminated lupus erythematosus; analysis of 34 cases. Arch, intern. Med. 90, 790 (1952).
Silver, S., u. G. A. Lindboom: Ein Fall von allgemeiner Amyloidosis ohne nachweisbare Ursache. Acta med. scand. 64, 529 (1926).
Snapper, J., L. B. Turner and H. L. Moscowitz: Multiple Myeloma. New York: Grüne [and] Stratton 1953.
Soffer, L. J., and R. Bader: Corticotropin and cortisone in acute disseminated lupus erythematosus. J. Amer. med. Ass. 149, 1002 (1952).
Soffer, L. J., and R. Bader, A. L. Southren, H. E. Weiner and R. L. Wolf: Renal manifestation of systemic lupus erythematosus. A.n. intern. Med. 54, 215 (1961).
Spector, W. G.: Labelled glycine in nephrotic syndrome. Clin. Sei. 13, 1 (1954).
Spiro, D.: The structural basis of proteinuria in man. Electron microscopic studies of renal biopsy specimens from patients with lipid nephrosis, amyloidosis, and subacute and chronic glomerulonephritis. Amer. J. Path. 35, 47 (1959).
Spííhler, O., u. H. U. Zollinger: Die diabetische Glomerulosklerose. Dtsch. Arch. klin. Med. 190, 321 (1943).
Svanborg, A.: Studies on renal hyperlipemia. Acta med. scand. Suppl. 264 (1951).
Symmers, W. St. C.: Primary amyloidosis. J. clin. Path. 9, 187 (1956).
Symposion über Chlorothiazid. Ed. F. Reubi. Ther. Umsch. 1959, 1.
Schnall, C., and J. S. Wiener: Nephrosis occurring during tolbutamide administration. J. Amer. med. Ass. 167, 214 (1958).
f Schupbach, A.: Persönliche Mitteilung.
Steffensen, K. A., and S. Brandt: Nephrotic syndrome during treatment with tridione. Nord. Med. 49, 134 (1953).
Talbot, N. B., J. D. Crawford and C. D. Cook: Application of homeostatic principles to the management of nephrotic patients. New Engl. J. Med. 256, 1080 (1957).
Tayeau, F.: Protéides et lipides sanguins. Bordeaux: Drovillard 1944.
Teilum, G.: Allergic hyperglobulinosis and hyalinosis (paramyloidosis) in reticuloendothelial system in Boeck’s sarcoid and other conditions; morphologic immunity reaction. Amer. J. Path. 24, 389 (1948).
Thorn, G. W.: Physiologic considerations in treatment of nephritis (Shattuck lecture). New Engl. J. Med. 229, 33 (1943).
Thorn, G. W. S. H. Armstrong, V. D. Davenport, L. M. Woodruff and F. H. Tyler: Chemical, clinical and immunological studies on the products of human plasma fractionation. J. clin. Invest. 24, 802 (1945).
Thorn, G. W., J. P. Merrill, S. Smith, M. Roche and T. F. Frawley: Clinical studies with ACTH and cortisone in renal diseases. Arch, intern. Med. 86, 319 (1950).
Tzanck, A., P. Klotz et A. Negream: Intolérance rénale à type de néphrose lipoidique survenue 5 semaines après une série de sel bismutique. Bull. Soc. méd. Hôp. Paris 1936, 1000.
Vallery-Radot, P., G. Mauric, R. Wolfromm et G. Guiot: Néphrose lipoidique secondaire à un traitement aurique. Bull. Soc. méd. Hôp. Paris 1942, 96.
P. Milliez, C. Laroche, P. Debray et J. Martin: Un cas de thrombose primitive des deux veines rénales. Bull. Soc. méd. Hôp. Paris 65, 611 (1949).
et F. Lhermitte: Douleurs abdominales par lésions pancréatiques au cours d’une néphrose lipoidique. Bull. Soc. méd. Hôp. Paris 1949, 616.
C. Laroche, P. Milliez et G. Lagrue: Résultats du traitement de la néphrose lipoidique par l’hydrocortisone. Presse méd. 1956, 381.
Traitement des néphroses par le deltacortisone. Intérêt des cures hormonales prolongées. Sem. Hôp. Paris 32, 3017 (1956).
Vernet, A., et J. J. Scheidegger: Recherche d’un syndrome humoral dans différentes formes cliniques du diabète. Helv. med. Acta 22, 384 (1955).
Vernier, R. L.: Studies on familial nephrosis: evidence for a unitarian concept. J. clin. Invest. 35, 741 (1956).
Vogt, H., F. Wüthrich u. F. Reubi: Über das Verhalten der alkalischen Phosphatase und der Lipase bei der Masugi-Nephritis mit und ohne Cortisonacetat. Helv. med. Acta 19, 357 (1952).
Vogtlin, G.: La crise abdominale aiguée au cours des syndromes néphrotiques. Ann. Méd. 1947, 211.
Volhard, F., u. T. Fahr: Die Brightsche Nierenkrankheit. Berlin: Springer 1914.
Die doppelseitigen hämatogenen Nierenerkrankungen. Hdb. inn. Med. 2. Aufl. Berlin: Springer 1931.
Vorbtjrger, C.: Neuere Diuretica. Ther. Umsch. 18, 182–189 (1961).
Wachstein, M.: Influence of experimental kidney damage on histochemically demonstrable lipase activity in the rat. Comparison with alkaline phosphatase activity. J. exp. Med. 84, 25 (1946).
Waldenstrom, H.: Über das Entstehen und Verschwinden des Amyloids beim Menschen. Klin. Wschr. 1927, 2235.
Wallace, S. L., D. J. Feldman, I. Berlin, C. Harris and I. A. Glass: Amyloidosis in Hodgkin’s disease. Amer. J. Med. 8, 552 (1950).
Walsh, J. R., and H. J. Zimmermann: Demonstration of LE phenomenon in patients with penicillin hypersensitivity. Blood 8, 65 (1953).
Weissenbach, J. M., J. Martineau, J. Brocard et A. Malinsky: Néphrose lipoidique après chrysothérapie. Bull. Soc. méd. Hôp. Paris 1936, 1076.
Weltmann, O., u. P. Biach: Zur Frage der experimentellen Cholesteatose. Z. exp. Path. Ther. 14, 367 (1913).
Westphal, O., O. Lüderitz, E. Eichenberger u. W. KeidErling: Über bakterielle Reizstoffe. I. Mitt.: Reindarstellung eines Polysaccharid-Pyrogens aus Bacterium coli. Z. Naturforsch. 7b, 536 (1952).
White, J. C.: Nephrosis occurring during trimethadione therapy. J. Amer. med. Ass. 139, 376 (1949).
Wilson, J. L., H. F. Root and A. Marble: Diabetic nephropathy: clinical syndrome. New Engl. J. Med. 245, 513 (1951).
Wilson, J. R., and C. R. Harrison: Cardiovascular, renal and general effects of large rapid plasma infusions. J. clin. Invest. 29, 251 (1950).
Winkler, A. W., S. H. Durlacher, H. E. Hoff and E. B. Man: Changes in lipid content of serum and of liver following bilateral renal ablation or ureteral ligation. J. exp. Med. 77, 473 (1943).
Wren, J. C., and R. L. Nutt: Nephrotic syndrome occurring during paramethadione therapy. Report of 1 case. J. Amer. med. Ass. 153, 918 (1953).
Wortham, J. T., and J. W. Headstream: Adrenalectomy in human diabetes (with advanced vascular disease). Diabetes 3, 376 (1954).
Wuhrmann, F., u. C. Wunderly: Die Bluteiweißkörper des Menschen. Basel: Benno Schwabe 1947.
Neurere klinische Untersuchungen über die Proteinurie. Bull. Schweiz. Akad.
med. Wiss. 8, 254 (1950).
Wuhrmann, F., u. C. Wunderly: Die Myocardose. Basel: Schwabe 1956.
Wuhrmann, F., u. C. Wunderly: Phäochromocytom — Insulom — Metastasierendes Dünndarmcarcinoid — Intermittierend akute Porphyrie — Periodische Krankheit mit Hämaturie und Hämoglobinurie — Lupus erythematodes visceralis — Makroglobulinämie mit Stimmbandkarzinom — Lebercirrhose und Myocardose. Helv. med. Acta 24, 256 (1957).
Zollinger, H. U.: Die diffuse, chronische Glomerulonephritis mit Vorherrschen des nephrotischen Einschlages (intrakapilläre Form). Schweiz, med. Wschr. 1950, 300.
Zollinger, H. U.: Über hyalin-tropfige Veränderungen der Nierenhauptstücke als Ausdruck von Eiweiß-Speicherung. Phasenmikroskopische Beobachtungen über Mitochondrien- funktionen. II. Schweiz. Z. allg. Path. 13, 146 (1950).
Zollinger, H. U.: Autoptische und experimentelle Untersuchungen über Lipoidnephrose, hervorgerufen durch chron. Quecksilbervergiftung. Schweiz. Z. allg. Path. 18, 155 (1955).
Zollinger, H. U.: Problèmes des néphrites et néphroses. J. Urol. méd. chir. 61, 581 (1955).
Zollinger, H. U.: Die Nephrosen (klinisch-anatom. Korrelationen ). Praxis 1961, 258.
Zubrod, C. G., S. L. Eversole and G. W. Dana: Amélioration of diabetes and striking rarity of acidosis in patients with Kimmelstiel-Wilson lésions. New Engl. J. Med. 245, 518 (1951).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1962 Springer-Verlag OHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Reubi, F., Cottier, P. (1962). Das nephrotische Syndrom. In: Heilmeyer, L., de Rudder, B., Schoen, R. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94842-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-94842-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94843-5
Online ISBN: 978-3-642-94842-8
eBook Packages: Springer Book Archive